Taiho Oncology, Inc.
Paulomi S. has over 20 years of work experience in the biotechnology industry. Paulomi is currently working as a Manager of Clinical Operations Logistics at Taiho Oncology, Inc. since November 2021. Prior to this, they worked at Infinity BiologiX as an Associate Director of Biospecimen Operations from March 2021 to November 2021 and as a Manager of Sample Processing Services from August 2020 to March 2021. Before joining Infinity BiologiX, Paulomi held various roles at RUCDR Infinite Biologics, including Sample Operations Manager from May 2019 to August 2020, Sample Operations Supervisor from March 2015 to May 2019, Principle Laboratory Technician and Team Lead from June 2002 to March 2015, and Senior Laboratory Technician from May 2001 to June 2002.
Paulomi S. attended Rutgers University–New Brunswick from 1998 to 2002, where they pursued a field of study in Genetics. However, no information is available regarding the completion of a degree during this period.
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com